Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

NCT00000635 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex
HIV Infections

Interventions

DRUG: Trifluridine
DRUG: Bacitracin zinc/Polymyxin B sulfate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]